CJC-1295 DAC, 2mg/vial

CJC-1295 DAC, 2mg/vial

Cas No. 863288-34-0

CJC 1295 DAC, a long acting GHRH polypeptide, causes the anterior pituitary’s somatotropes to release growth hormone. DAC conjugated CJC 1295, makes this GHRH have a half life of more than a week (approx. 8 days). GHRH is released in pulses in the body which alternate with corresponding pulses of somatostatin (growth-hormone inhibiting-hormone). Ghrelin, released from the gut which circulates and acts as a hunger hormone, has synergistic activity in the body with GHRH and also suppresses somatostatin to make way for the GHRH pulse. Studies shows that combining GHRP with CJC 1295 DAC, significantly increase the release of GH and IGF-1 production.

CJC-1295 DAC is a long-acting version of GHRH (Growth Hormone Releasing Hormone) which has had its half-life extended to 8 days. This is convenient as it means the product only needs peptide injection once or twice per week for continuously elevated levels of HGH and IGF-1. The advantage of using CJC-1295 DAC instead of actual GH injections is that injecting HGH 191 amino acid polypeptide hormone shuts down the natural production and therefore when injections cease, the ability to produce peptide hormones may be impaired requiring time to recover. Since CJC-1295 DAC stimulates the growth factor peptide release of production, this CJC1295 GHRH products on sale for research use only.

CJC-1295 has shown some amazing results as a growth hormone releasing hormone (GHRH) analog. Not only has CJC-1295 shown potential to increase growth hormone and IGF-I secretion and effects, but it has been able to do so in very large amounts. CJC - 1295 Stimulates GH and IGF-1 Secretion, and will keep a steady increase of growth hormone and IGF-1 with no increase in prolactin, leading to intense fat loss, and increases protein synthesis for more muscle growth.